The U.S. is not short of tungsten ore, and it is not short of finished missiles. It is short of the chemical step in between: ammonium paratungstate, the powder precursor that turns raw ore into the material defense manufacturing actually needs. The Pentagon's $450 million investment in Elmet Group names that specific missing node, and the instrument used to fund it is the more revealing part of the move.
The deal is a redeemable preferred-equity stake, not a grant and not a purchase order. Equity is what a government writes when it wants alignment, not throughput. A grant pays for a plant; an equity stake buys a return if the plant works and a loss if it does not, which is the structure the Office of the Assistant Secretary of War for Industrial Base Policy and the Economic Defense Unit chose this time. Washington is treating the APT gap as an industrial-base problem with a private-sector solution, not a wartime procurement line.
The geography follows the gap. New jobs land in Coldwater, Michigan, and Lewiston, Maine, where the APT plant is being built. Euclid, Ohio, keeps its existing manufacturing. Nevada gets the upstream mining expansion. Roughly 1,200 downstream positions feed F-35 production lines, Patriot PAC-3 interceptors, Trident D5 submarine-launched ballistic missiles, the Next Generation Interceptor, the Precision Strike Missile, and Virginia- and Columbia-class submarine programs. The 85 percent China-share figure is the strategic floor under the bet.
One facility does not flip a global processing share, and "the only independent APT facility in North America" is agency- and company-supplied framing. The mechanism survives the qualifier: when a defense supply chain breaks at one chemical rung, the rebuild is funded as a financial bet on a single private node, not a commodity subsidy.